Unstable coronary artery disease: Need for long-term antithrombotic treatment? Aspirin alone may not be the ideal antithrombotic strategy, but that's what we have adequate trial data for

Cardiovascular Research

Volumn 33, Issue 2, 1997, Pages 295-296

  Patrono, Carlo ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; HEPARIN; PLACEBO;

CORONARY ARTERY DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY; THROMBOSIS;

ANTICOAGULANTS; ASPIRIN; CLINICAL TRIALS; CORONARY DISEASE; HUMANS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS;

EID: 0031032946     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00244-1     Document Type: Short Survey

References (9)

1. Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. New Engl J Med 1983;309:396-403.
2. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827-830.
3. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-68.
4. Patrono C. Aspirin as an antiplatelet drug. New Engl J Med 1994;330:1287-1294.
5. Théroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. New Engl J Med 1988;319:1105-1111.
6. Cohen M, Adams P, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-q-wave infarction in nonprior aspirin users. Circulation 1994;89:81-88.
7. Cairns JA, Lewis HD Jr., Meade TW, Sutton GC, Théroux P. Antithrombotic agents in coronary artery disease. Chest 1995;108:380S-400S.
8. FRISC Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet 1996;347:561-568.
9. Klein W, FRIC Study Group. Low molecular weight heparin in the initial and prolonged treatment of unstable coronary artery disease - the fragmin in unstable coronary heart disease study (FRIC). Eur Heart J 1996;17:306 (Abstract).